Zomedica Corp
Change company Symbol lookup
Select an option...
ZOM Zomedica Corp
AMANX Amana Mutual Funds Trust Income Fund Investor
BAC Bank of America Corp
GMS GMS Inc
$VX3MN.X CBOE Near-Term VIX3M
TSHA Taysha Gene Therapies Inc
PTPI Petros Pharmaceuticals Inc
MGDPF Marathon Gold Corp
IDEX Ideanomics Inc
CFX Colfax Corp
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Zomedica Corp., formerly Zomedica Pharmaceuticals Corp., is a development stage veterinary diagnostic and pharmaceutical company. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. It is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. It is developing ZM-017 as a canine cancer liquid biopsy platform.

Closing Price
$0.85
Day's Change
-0.1251 (-12.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.9405
Day's Low
0.83
Volume
(Average)
Volume:
80,755,756

10-day average volume:
83,833,990
80,755,756

Display:

Providers:

UpdateCancel
6 providers

No press release found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.